Bi-Monthly Webinar: ISSUP Nigeria Knowledge Update Series (Fourteenth Session)
ISSUP Nigeria would like to invite you to their next Bi-Monthly Webinar in the Knowledge Update Series. This Webinar will centre on 'The Use of Methamphetamine in Nigeria: Trend and Threat Analysis'.
Time: 3PM Nigeria Time | 3PM UK Time
Register for the Webinar
Learning Outcomes:
- Learn about the effects of methamphetamine on the brain
- How to identify the physical and mental symptoms and signs of methamphetamine abuse
- Highlight challenges associated with the treatment of methamphetamine use disorders
- Tips on curbing the use, production and trafficking of methamphetamine
Presenter:
Dr. Arit Esangbedo
Dr. Esangbedo obtained her medical degree from the University of Calabar in Nigeria, and an MBA in healthcare management from Walden University in Baltimore, Maryland, United States. She is a Fellow of the West African College of Physicians (Psychiatry) and an internationally certified addiction practitioner. Dr. Esangbedo currently serves as a consultant psychiatrist at substance use disorders/research unit of the Federal Neuropsychiatric Hospital in Yaba, Lagos, where she has worked since 2009. Given her strong interest in substance abuse prevention, diagnosis, and treatment, she has devoted much of her work to improving the substance abuse unit at the Federal Neuropsychiatric Hospital, particularly focusing on addressing the unique needs of adolescents and women. Dr. Esangbedo is a member of the International Society of Substance Use Prevention and Treatment Professionals (ISSUP) and a participant at the ISSUP 2022 Global Conference in Abu Dhabi.
Moderators:
Dr. Martin O. Agwogie
National President, ISSUP Nigeria Chapter
Dr. Bawo O. James
Publicity Secretary/Mobilization ISSUP Nigeria Chapter
Webinars and online events delivered and hosted by the International Society of Substance Use Professionals (ISSUP) are provided for informational purposes only. They are educational in nature and do not constitute medical advice, diagnosis or treatment.